Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process? - Wikidata - wikimedia - TriplyDB

Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?

Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?

http://www.wikidata.org/entity/Q33219607

about

New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations.Approaching clinical proteomics: current state and future fields of application in fluid proteomics.Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid Biomarker discovery in neurodegenerative diseases: a proteomic approach.Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases Clinical proteomics in neurodegenerative disorders.Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models Proteomics of human neurodegenerative diseases Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord Proteomic strategies in multiple sclerosis and its animal models Proteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research.Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.Proteomic analysis in cerebrospinal fluid of patients with atypical nonketotic hyperglycinemia and pulmonary hypertension - A pilot study.Cerebrospinal fluid drainage through the diploic and spinal epidural veins.Cranial arachnoid protrusions and contiguous diploic veins in CSF drainage.Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis 1 / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis

P2860

Q26783410-B9656BAB-0ACC-405F-A7B5-11510E3AD324 Q28307028-6972F4E5-6D4E-45D7-8059-B2CBBA7A1EFF Q33282300-6AEA4C35-9B22-4F76-9D04-0CF74A42306C Q33467523-EECF64F8-69EB-4A1E-B0DB-374EFCF248AA Q33536646-9C6C92CE-BEEA-4694-B1DB-5A265EC6AEA9 Q33731693-32D4A734-4253-4418-960F-BA39EF30429F Q34078408-7AEEE02D-3874-410C-A7D3-A4A00CDBC8B3 Q34125681-C5123D91-B24C-42EE-B389-7C57D9847324 Q35377133-6CE2A957-F05C-4DD2-9653-773A3EE81DD1 Q35880037-8F399571-E3BD-482E-AE00-71C4BD2BD2B2 Q36135242-CAF456DA-D587-4B90-A6D6-8A06DDA92908 Q36615226-F2451FC1-51E9-45A0-8758-6AFC3FAD499D Q36974613-BD7BE131-E78B-43E6-861D-BF69B6FDDE01 Q37086170-8767513A-DB11-468C-8F59-BBA001ABB290 Q37248957-5E48E30E-CFC1-430A-A8D3-0C5042D7B868 Q37260477-37E85724-84A1-4F8A-83A2-8B593C93B34F Q37276639-2CCB9776-DAB3-4B0A-9CA8-249F4FFCEE07 Q37347220-AB97902A-BA60-435A-9FDE-D1650D379B25 Q37818319-01F09173-6EB3-453D-8865-046FB59B0804 Q38037155-D75E8AC6-BF2B-41D5-9AC8-5776C01004DA Q38063697-17549639-CD94-4795-BF80-92A7A83F549B Q38113846-D4B7F165-3C79-4E3C-8856-C7B23AEC948E Q38207538-3F2C54AE-0D17-4F4E-83D2-3D48D3865C88 Q38643847-A168FB9A-37F3-4127-AFE1-02A267D2B55E Q39366291-A076E2F8-648B-4B6E-9407-611447F63805 Q42784787-141C2BBC-FA27-4971-92A2-7F97D86BBC3A Q53422343-63018CD1-6C7C-4B98-8231-6C1E5BAA2178 Q55058340-A6AF13EB-834D-4EA0-8515-590E5B5909BB Q57267921-D5A64B47-46AA-4210-A923-7DABB8E93D61 Q58181716-BC7DF9E0-41E6-4AB0-BF88-81C53CE86ACB

P2860

Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?

http://www.wikidata.org/entity/Q33219607

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Truncated cystatin C in cerebr ...... rtefact or biological process?

@ast

Truncated cystatin C in cerebr ...... rtefact or biological process?

@en

type

label

Truncated cystatin C in cerebr ...... rtefact or biological process?

@ast

Truncated cystatin C in cerebr ...... rtefact or biological process?

@en

prefLabel

Truncated cystatin C in cerebr ...... rtefact or biological process?

@ast

Truncated cystatin C in cerebr ...... rtefact or biological process?

@en

P1433

Q33219607-A61C2CD6-F44D-474F-94F3-BBBD53F3D975

P1476

Q33219607-11B37A3D-CEF8-47EA-A1A8-3D0E975F937B

P2093

Q33219607-574C3DFB-D677-4BD7-AA97-6CA8E2026B22

Q33219607-5A4AEDAA-9823-49BA-8FB2-29D3769D0C3D

Q33219607-AC0E776A-44F7-4079-98BB-0DAACCB0BE04

Q33219607-EC9CF4E0-658D-4044-A7DC-1F18AF61C50F

Q33219607-F7705566-5A7E-4E5C-A648-CE52F97ADE56

P2860

Q33219607-1621AAB3-852F-41DB-A3EF-97428B658A73

Q33219607-1CACC944-82DD-46F4-A695-14FBE93418B8

Q33219607-20BFB3F1-1C31-4E2A-BEF5-50C709D31E48

Q33219607-2DE2E4FF-BABB-4029-99FD-202A173BC72D

Q33219607-9E9C1964-40E8-416F-A52F-E96C77C58F0C

Q33219607-D51C9419-CA52-489A-89B3-76076DDC1471

Q33219607-E28AE09A-8047-462C-8A15-B3AA11350345

Q33219607-F3FBEB33-0F27-4B88-892A-383552BC7265

P304

Q33219607-95668B83-5058-4307-8286-D5C4ADFCC7ED

P31

Q33219607-FD2437DE-FF97-4EE5-9248-4E3CE5922405

P356

Q33219607-7152AD35-B589-4BC7-8BFE-F9A2E5A2ACFC

P433

Q33219607-6DF9C557-A2DD-4F24-835F-3F56BC4054CE

P478

Q33219607-C4A08015-BFD8-4339-9DE4-998E2393519A

P577

Q33219607-43E7DEE7-7873-43C8-8A1F-A80BF33A71A7

P698

Q33219607-D9013288-29B9-4A98-A89F-D0D27931086C

P356

P1433

P1476

Truncated cystatin C in cerebr ...... rtefact or biological process?

@en

P2093

Denis F Hochstrasser

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Sanchez

http://www.w3.org/2001/XMLSchema#string

Odile Carrette

http://www.w3.org/2001/XMLSchema#string

Pierre R Burkhard

http://www.w3.org/2001/XMLSchema#string

Severine Hughes

http://www.w3.org/2001/XMLSchema#string

P2860

Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.

Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase.

Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes.

Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS.

Modulation of phagocytosis-associated respiratory burst by human cystatin C: role of the N-terminal tetrapeptide Lys-Pro-Pro-Arg.

Characterization of cystatin C from bovine parotid glands: cysteine proteinase inhibition and antiviral properties.

Molecular cloning and N-terminal analysis of bovine cystatin C. Identification of a full-length N-terminal region.

Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases

P304

3060-3065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.200402039

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16021609

http://www.w3.org/2001/XMLSchema#string